News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
658,309 Results
Type
Article (56970)
Company Profile (105)
Press Release (601234)
Section
Business (183567)
Career Advice (2850)
Deals (34514)
Drug Delivery (92)
Drug Development (78218)
Employer Resources (167)
FDA (15988)
Job Trends (14879)
News (322404)
Policy (33038)
Tag
Academia (2738)
Africa (913)
Alliances (45985)
Alzheimer's disease (1131)
Approvals (15917)
Arizona (128)
Artificial intelligence (68)
Asia (39039)
Australia (6842)
Bankruptcy (316)
Best Places to Work (11149)
Biosimilars (64)
Biotechnology (72)
C2C Services and Suppliers (72534)
California (1684)
Canada (874)
Cancer (495)
Career advice (2403)
Cell therapy (131)
China (138)
Clinical research (61319)
Collaboration (139)
Colorado (78)
Connecticut (72)
COVID-19 (2539)
Cystic fibrosis (73)
Data (308)
Diabetes (74)
Diagnostics (6133)
Drug pricing (77)
Earnings (63239)
Employer resources (143)
Europe (88511)
Events (95239)
Executive appointments (160)
FDA (16219)
Florida (255)
Funding (137)
Gene therapy (92)
Georgia (62)
GLP-1 (510)
Government (4702)
Healthcare (18985)
Hotbed/Location (436712)
Illinois (277)
Indiana (138)
Infectious disease (2566)
Inflammatory bowel disease (92)
Interviews (543)
IPO (15538)
Job creations (3833)
Job search strategy (2032)
Kansas (96)
Layoffs (447)
Legal (8019)
Lung cancer (111)
Manufacturing (85)
Maryland (381)
Massachusetts (1289)
Medical device (13009)
Medtech (13014)
Mergers & acquisitions (18880)
Metabolic disorders (227)
Michigan (125)
Minnesota (191)
Neuroscience (1275)
New Jersey (556)
New York (566)
NextGen Class of 2024 (6710)
Non-profit (4622)
North Carolina (612)
Northern California (765)
Obesity (137)
Ohio (100)
Opinion (201)
Patents (71)
Pennsylvania (527)
People (58652)
Phase I (18961)
Phase II (26989)
Phase III (20148)
Pipeline (110)
Policy (59)
Postmarket research (2515)
Preclinical (7969)
Press Release (68)
Rare diseases (133)
Real estate (6332)
Recruiting (66)
Regulatory (21296)
Research institute (2406)
Resumes & cover letters (428)
South America (1260)
Southern California (709)
Startups (3400)
Texas (227)
United States (7947)
Vaccines (494)
Washington State (227)
Weight loss (117)
Date
Today (113)
Last 7 days (618)
Last 30 days (2321)
Last 365 days (35334)
2024 (24876)
2023 (38114)
2022 (48907)
2021 (53993)
2020 (53239)
2019 (47009)
2018 (35775)
2017 (32159)
2016 (31607)
2015 (37002)
2014 (30023)
2013 (26252)
2012 (27706)
2011 (28106)
2010 (26291)
658,309 Results for "united states department of labor".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Lone Star Bio
Plus Therapeutics Receives $3 Million Award Recommendation from the United States Department of Defense
Plus Therapeutics, Inc. today announced it has been selected for funding by the Department of Defense (DoD) office of the Congressionally Directed Medical Research Programs (CDMRP).
April 22, 2024
·
6 min read
Gemina Laboratories Commences Trading on the OTCQB Market in the United States
Gemina Laboratories Ltd. is pleased to announce that it has qualified for trading on the OTCQB Venture Market in the United States operated by the OTC Markets Group Inc. and the Company’s common shares have commenced trading on the OTCQB under the symbol “GLABF.” The Company’s common shares will continue to trade on the CSE Exchange under the symbol “GLAB” and on the Frankfurt Exchange under the symbol “817".
June 20, 2024
·
4 min read
Deals
Telix Announces Launch of Proposed Initial Public Offering in the United States
Telix Pharmaceuticals Limited (the “Company” or “Telix”) today announces the launch of its initial public offering in the United States (the “Offering”) of 17,000,000 American Depositary Shares (“ADSs”), each representing one ordinary share in Telix.
June 5, 2024
·
6 min read
Deals
Telix Files Registration Statement for Proposed Initial Public Offering in the United States
Telix Pharmaceuticals Limited announces that it has filed a registration statement on Form F-1 with the United States Securities and Exchange Commission relating to a proposed initial public offering of its American Depository Shares, representing the Company’s ordinary shares, in the U.S. Telix has applied to list the ADSs on the Nasdaq Global Market under the symbol “TLX”.
May 17, 2024
·
5 min read
NewAmsterdam Pharma Announces Issuance of Composition of Matter Patent for Obicetrapib by the United States Patent and Trademark Office
NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”) today announced that the United States Patent and Trademark Office (“USPTO”) has issued U.S. Patent No. 12,006,305, titled “Salts of Obicetrapib and Processes for their Manufacture and Intermediates Thereof.”
June 11, 2024
·
7 min read
BioCapital
Adial Pharmaceuticals Granted Key Patent from the United States Patent and Trademark Office
Adial Pharmaceuticals, Inc. today announced patent number 11957664 was issued April 16, 2024 by the United States Patent and Trademark Office.
April 22, 2024
·
4 min read
Pharm Country
Applied DNA Receives Approval for TR8(TM) Pharmacogenomic (PGx) Testing Service from New York State Department of Health
Applied DNA Sciences, Inc. (NASDAQ:APDN) (“Applied DNA” or the “Company”), a leader in PCR-based DNA technologies, today announced that the New York State Department of Health (“NYSDOH”) approved the Company’s TR8™ PGx (“TR8") pharmacogenomic (PGx) testing service.
June 13, 2024
·
5 min read
News
Rising Pharmaceuticals announces commercial availability of Edetate calcium disodium injection in the United States
September 13, 2024
·
17 min read
Press Releases
Avicanna Announces United States Patent and Trademark Office Issuance of Patent on Topical Technology
August 27, 2024
·
7 min read
Business
Reveal Genomics® to Evaluate Prospective Real-time Performance of HER2DX® Genomic Test in the United States
Reveal Genomics® to Evaluate Prospective Real-time Performance of HER2DX ® Genomic Test in the United States.
June 18, 2024
·
4 min read
1 of 65,831
Next